Opticept Technologies AB
Opticept Technologies AB develops and sells optical sensors for food safety and quality control, generating revenue primarily through product sales and service contracts.
Business. Opticept Technologies AB (OPTIFR.ST) is a food and beverage company operating within the fishing and farming industry. The firm is headquartered in Sweden and is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Opticept Technologies AB (OPTIFR.ST) is a food and beverage company operating within the fishing and farming industry. The firm is headquartered in Sweden and is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Opticept Technologies AB operates with a current ratio of 0.62, indicating that its current assets are insufficient to cover its current liabilities. The company's liquidity position is further constrained by a negative net cash position after subtracting total debt, which raises concerns about its ability to meet short-term obligations without external financing. Custom valuations show a liquidity_fpt of 0.45, below the industry median of 0.72, suggesting a weaker liquidity profile relative to peers.
Profitability metrics reveal significant underperformance. The company reported a return on equity (ROE) of -64.91% and a return on assets (ROA) of -49.08%, both far below the industry median ROE of 12.3% and ROA of 8.1%. Gross profit margin of 45.5% is in line with the industry median of 44.2%, but operating and net losses of -619.7% and -664.5% respectively highlight operational inefficiencies and cost overruns.
Geographically, Opticept's revenue is concentrated in its domestic market, with 82% of total revenue derived from Sweden. This concentration increases exposure to local economic conditions and regulatory changes. The company has no disclosed international segments, limiting diversification benefits.
Growth prospects are mixed. While the company's current FY revenue outlook is flat, the next FY is projected to see a 50% increase in revenue, driven by new product launches and expanded distribution channels. However, historical revenue growth has been negative, with a 12-month decline of 18%. Analysts have set a mean revenue estimate of 41 million SEK for the next fiscal year, a 47% increase from the 27.2 million SEK reported in the latest period.
Risk factors include a medium liquidity risk due to negative operating cash flow of -87.1 million SEK and a free cash flow deficit of -179.5 million SEK. The company's debt-to-equity ratio of 0.17 is low, but the negative net cash position and lack of dilution risk (low) suggest potential for equity issuance if liquidity pressures persist. Adjustments in custom valuations reflect a 15% downward revision to earnings estimates due to recent operational underperformance.
Recent events include a Q4 earnings report that showed a net loss of 180.98 million SEK, a significant deterioration from the prior year. The company also announced plans to launch a new line of optical sensors in early 2025, which could drive future revenue growth. Analysts have set a mean price target of 4.75 SEK, unchanged from the previous quarter, reflecting cautious optimism about the company's turnaround potential.
- Opticept Technologies AB is experiencing severe operational losses, with a net loss of 180.98 million SEK in the latest reporting period.
- The company's liquidity position is weak, with a current ratio of 0.62 and negative net cash after debt.
- Despite poor profitability, the company is projected to see a 50% revenue increase in the next fiscal year, driven by new product launches.
- Revenue is heavily concentrated in Sweden, increasing exposure to local economic and regulatory risks.
- Analysts have set a mean price target of 4.75 SEK, unchanged from the previous quarter, indicating cautious optimism.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,21 |
| Revenue | —no estimate | —no estimate | 41,0M SEK |
| Operating income | —no estimate | —no estimate | -18,0M SEK |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Opticept Technologies AB Market data — financials · 2026-05-28
- Opticept Technologies AB Market data — analyst estimates · 2026-05-28